What lacks a brain but has the ability to swiftly avoid setting off our body’s intruder detectors, bringing its own blueprints into our cells to make more of itself, and in some cases, cause cancer? Human papillomavirus.

In 2013, Academy Award-winning actress Angelina Jolie wrote a now famous opinion piece for the New York Times detailing her journey involving genetic testing for breast and ovarian cancer.

Coccidioidomycosis, or “cocci” for short, is the medical term for Valley fever, an infectious disease that affects thousands of people in Arizona every year.

Noninvasive prenatal testing (NIPT), one of the newest additions in genomic testing, is a simple blood test that can tell a lot about a baby’s likelihood of having certain genetic conditions.

Do I really want to know? This is one of the most important questions people ask themselves before genetic testing. And this conundrum is more relevant for conditions like Alzheimer’s disease.

Most commonly, asthma manifests itself as having difficulty breathing, accompanied by any number of other symptoms, including, chest pain or tightness, anxiety, fast heart rate, cough, throat irritation and/or wheezing.

Most people familiar with cancer treatment know of three main options: surgery, radiation and chemotherapy. But a newer option, called immunotherapy, is creating quite a buzz across the cancer community.

There is power in numbers. When a researcher is studying the causes of a human disease, the more people involved in the study, the greater the probability that the study will generate useful results.